Skip to main content
. Author manuscript; available in PMC: 2023 Jul 17.
Published in final edited form as: Vaccine. 2021 Feb 12;39(10):1485–1492. doi: 10.1016/j.vaccine.2021.02.004

Table 1.

Comparison of demographic characteristics and vaccination status of children selected for the serosurvey participation by hepatitis B testing status, across survey sites — Ukraine, 2017

Characteristics Tested for hepatitis B Not tested for hepatitis B
(refused or not enough sample)
P value
No. % No. %
Zakarpattya
Total children 1,268 100.0 313 100.0 n/a
 2006-2009 cohorts 667 52.6 124 39.6 <0.001
 Female 593 46.8 149 47.6 0.790
 Received ≥3 doses of HepB 538 42.4 109 34.8 0.024
Sumy
Total children 1,380 100.0 213 100.0 n/a
 2006-2009 cohorts 699 50.7 99 44.6 0.100
 Female 661 47.9 115 54.0 0.100
 Received ≥3 doses of HepB 1,021 74.0 72 33.8 <0.001
Odessa
Total children 1,265 100.0 269 100.0 n/a
 2006-2009 cohorts 663 52.4 107 39.8 <0.001
 Female 611 48.3 141 52.4 0.220
 Received ≥3 doses of HepB 679 53.7 107 39.8 <0.001
Kyiv City
Total children 683 100.0 116 100.0 n/a
 2006-2009 cohorts 352 51.5 47 40.5 0.029
 Female 340 49.8 45 38.8 0.290
 Received ≥3 doses of HepB 347 50.8 54 46.6 0.399

Note. Doses of any vaccines containing hepatitis B component are included. Immunization information reflects the status as of July–August 2017, prior to the survey specimen collection in late August–September 2017; n/a – not applicable; HepB, hepatitis B-containing vaccine